Federal Register Notice
16 CFR Parts 801 and 803: Premerger Notification; Reporting and Waiting Period Requirements
Date
Q and A on the Notice of Proposed Rulemaking for the HSR Filing Process
Displaying 561 - 580 of 4950
FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review
Date
The Federal Trade Commission, with the concurrence of the Assistant Attorney General of the Antitrust Division of the U.S. Department of Justice, is proposing changes to the premerger notification...
Statement of Chair Lina M. Khan Joined by Commissioners Slaughter and Bedoya Regarding Proposed Amendments to the Premerger Notification Form and the Hart-Scott-Rodino Rules
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
In Re Bystolic Antitrust Litigation
Date
Citation Number
23-410
Federal Court
U.S. Circuit Court of Appeals for the Second Circuit
The Commission urges the Second Circuit to reverse the district court’s decision dismissing the private plaintiffs’ reverse-payment complaints for failure to state a claim and clarifies the...
File
Brief of Amicus Curiae
(443.34 KB)
FTC Files Amicus Brief in Bystolic Antitrust Litigation Supporting Competition in the Hypertension Drug Market
Date
The Federal Trade Commission filed a friend-of-the-court (amicus) brief in the U.S. Court of Appeals for the Second Circuit, clarifying the legal standards that apply in certain antitrust cases...
FTC Policy Director Issues Statement Commending Maine’s Repeal of Certificate of Public Advantage Law
Date
The Federal Trade Commission has learned that the state of Maine recently enacted legislation repealing the state’s Hospital and Health Care Provider Cooperation Act , which allowed for certain...
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
Date
As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued a compulsory...
FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement
Date
In a comment to North Carolina House Health Committee members, the Federal Trade Commission staff opposed a bill pending before the state legislature attempting to prevent antitrust authorities from...
FTC Approves Final Order Requiring Anchor Glass Container Corp. to Drop Noncompete Restrictions That It Imposed on Workers
Date
Following a public comment period, the Federal Trade Commission finalized a consent order settling charges that Anchor Glass Container Corp. illegally imposed noncompete restrictions on more than 300...
FTC Approves Publication of Federal Register Notice on Revisions to Parts 0-4 of the Commission’s Rules of Practice
Date
The Federal Trade Commission voted to modify several sections of the agency’s Rules of Practice to reflect the creation of the FTC’s Office of Technology, revise the Commission’s administrative...
Anchor Glass
Type of Action
Administrative
Last Updated
FTC Matter/File Number
2110182
Docket Number
C-4793
Case Status
Pending
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Date
The Federal Trade Commission and the U.S. Department of Justice, Antitrust Division released a summary of a two-day workshop that explored new approaches to enforcement of the antitrust laws in the...
FTC Approves Final Order Requiring Mastercard to Stop Blocking the Use of Competing Debit Payment Networks
Date
Following a public comment period, the Federal Trade Commission finalized a consent order settling charges that Mastercard used illegal business tactics to force merchants to route debit card payments...
Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.
Date
In response to the announcement that Boston Scientific Corporation and non-vascular stent manufacturer M.I. Tech Co., Ltd. have terminated their $230 million purchase agreement, Federal Trade...
FTC Deepens Inquiry into Prescription Drug Middlemen
Date
As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued compulsory...
Amgen Inc. and Horizon Therapeutics plc, FTC v.
Type of Action
Federal
Last Updated
FTC Matter/File Number
231 0037
Case Status
Pending
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
Date
The Federal Trade Commission is seeking to block biopharmaceutical giant Amgen Inc. from acquiring Horizon Therapeutics plc, saying the deal would allow Amgen to leverage its portfolio of blockbuster...
Displaying 561 - 580 of 4950